|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression increases expression |
ISO |
4-phenylbutyric acid results in decreased expression of AARS1 mRNA 4-phenylbutyric acid results in increased expression of AARS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:111,759,781...111,784,237
Ensembl chr 8:111,759,776...111,784,296
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of ACSL4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr X:141,100,989...141,173,792
Ensembl chr X:141,100,989...141,173,531
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of ACTA2 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Adam17 |
a disintegrin and metallopeptidase domain 17 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ADAM17 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ADAM17 protein] |
CTD |
PMID:27638906 |
|
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of FN1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25398788 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Ahsa1 |
AHA1, activator of heat shock protein ATPase 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of AHSA1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr12:87,313,189...87,320,772
Ensembl chr12:87,313,253...87,320,772
|
|
G |
Ajuba |
ajuba LIM protein |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of AJUBA mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:54,804,926...54,815,118
Ensembl chr14:54,804,929...54,815,015
|
|
G |
Akr1c20 |
aldo-keto reductase family 1, member C20 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of AKR1C1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]] 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:25398788 PMID:28245985 PMID:31298478 PMID:32283200 PMID:36640941 PMID:37148176 More...
|
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt2 |
thymoma viral proto-oncogene 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT2 protein] |
CTD |
PMID:36640941 |
|
NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
|
|
G |
Akt3 |
thymoma viral proto-oncogene 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT3 protein] |
CTD |
PMID:36640941 |
|
NCBI chr 1:176,847,642...177,091,688
Ensembl chr 1:176,847,639...177,085,769
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
multiple interactions |
EXP |
ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] |
CTD |
PMID:32407927 |
|
NCBI chr 1:87,025,724...87,029,328
Ensembl chr 1:87,025,724...87,029,328
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of APAF1 protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of APAF1 protein] |
CTD |
PMID:33651226 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
App |
amyloid beta precursor protein |
affects activity |
ISO |
4-phenylbutyric acid affects the activity of APP protein |
CTD |
PMID:16204253 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased phosphorylation of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 4-phenylbutyric acid results in decreased expression of ATF4 protein 4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Leflunomide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [perhexiline maleate results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of ATF4 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of ATF4 protein] |
CTD |
PMID:27470132 PMID:27484784 PMID:27634458 PMID:28063906 PMID:28844859 PMID:28988120 PMID:29653943 PMID:30025493 PMID:30602124 PMID:30980806 PMID:31364909 PMID:32578922 PMID:33309543 PMID:33651226 PMID:34175825 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36030031 PMID:36473502 PMID:37741534 More...
|
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; [4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; [4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein 4-phenylbutyric acid results in decreased expression of ATF6 protein |
CTD |
PMID:20165829 PMID:26804720 PMID:27578021 PMID:27638906 PMID:28245985 PMID:30796460 PMID:30980806 PMID:31298478 PMID:31364909 PMID:33651226 PMID:34520753 PMID:35413383 PMID:36030031 PMID:36646296 PMID:37148176 PMID:37692514 More...
|
|
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
|
|
G |
Atf6b |
activating transcription factor 6 beta |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of ATF6B protein] |
CTD |
PMID:34214594 |
|
NCBI chr17:34,866,120...34,874,048
Ensembl chr17:34,866,120...34,874,048
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 protein] |
CTD |
PMID:34175825 |
|
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
|
|
G |
Atg3 |
autophagy related 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of ATG3 protein] |
CTD |
PMID:35398186 |
|
NCBI chr16:44,979,192...45,008,901
Ensembl chr16:44,979,148...45,008,901
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of ATG4B protein 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of ATG4B protein] |
CTD |
PMID:36640941 |
|
NCBI chr 1:93,682,627...93,717,328
Ensembl chr 1:93,679,222...93,718,332
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] |
CTD |
PMID:34175825 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Bax |
BCL2-associated X protein |
decreases expression multiple interactions increases expression |
EXP ISO |
4-phenylbutyric acid results in decreased expression of BAX protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of BAX protein] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of BAX protein]] 4-phenylbutyric acid results in increased expression of BAX protein |
CTD |
PMID:25450231 PMID:27816613 PMID:29306025 PMID:30980806 PMID:31364909 PMID:33651226 PMID:33771661 PMID:34214594 PMID:37148176 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bbc3 |
BCL2 binding component 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BBC3 protein] |
CTD |
PMID:34214594 |
|
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Silver Compounds results in decreased expression of BCL2 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]] 4-phenylbutyric acid results in increased expression of BCL2 protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] |
CTD |
PMID:27816613 PMID:29306025 PMID:33651226 PMID:34214594 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l11 |
BCL2 like 11 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] |
CTD |
PMID:34214594 |
|
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
|
|
G |
Bcl6 |
B cell leukemia/lymphoma 6 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of BCL6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
|
|
G |
Becn1 |
beclin 1, autophagy related |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Ethylmercury Compounds results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of BECN1 protein] |
CTD |
PMID:27511942 PMID:33127495 PMID:35398186 PMID:36058351 PMID:36700298 |
|
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of BIRC5 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein] |
CTD |
PMID:33127495 |
|
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of CAMKK2 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 5:122,856,064...122,918,295
Ensembl chr 5:122,869,233...122,917,472
|
|
G |
Capn2 |
calpain 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in increased expression of CAPN2 protein] |
CTD |
PMID:34973135 |
|
NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression increases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CARS1 mRNA 4-phenylbutyric acid results in increased expression of CARS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 PMID:37692514 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of CASP12 protein]]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased activity of CASP12 protein] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of CASP12 protein]; 4-phenylbutyric acid results in increased expression of and results in decreased cleavage of CASP12 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased degradation of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP12 protein] |
CTD |
PMID:17459145 PMID:27638049 PMID:28245985 PMID:33651226 PMID:33771661 PMID:33922211 PMID:36646296 More...
|
|
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Cyclosporine results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP3 protein] 4-phenylbutyric acid results in decreased expression of CASP3 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased activity of and results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP3 protein]]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form] |
CTD |
PMID:21804221 PMID:24865413 PMID:25450231 PMID:25870318 PMID:27578021 PMID:27638049 PMID:27638906 PMID:29306025 PMID:29981725 PMID:30980806 PMID:31364909 PMID:32407927 PMID:32569804 PMID:32879258 PMID:33651226 PMID:33771661 PMID:33922211 PMID:34214594 PMID:35033536 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein] |
CTD |
PMID:24865413 PMID:25870318 PMID:33771661 PMID:33922211 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Ficusin results in increased activity of CASP8 protein] |
CTD |
PMID:31364909 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of CASP9 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CASP9 protein modified form] |
CTD |
PMID:29306025 PMID:32569804 PMID:33651226 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
EXP |
4-phenylbutyric acid results in decreased expression of CCL2 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CCL2 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CCL2 mRNA] |
CTD |
PMID:28698385 PMID:35413383 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl8 |
C-C motif chemokine ligand 8 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CCL8 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
EXP |
4-phenylbutyric acid promotes the reaction [[2,3,5-trichloro-6-phenyl-(1,4)benzoquinone co-treated with malondialdehyde-low density lipoprotein, human] results in increased expression of CD36 mRNA] |
CTD |
PMID:32434321 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein] |
CTD |
PMID:36058351 |
|
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
[4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN1A mRNA 4-phenylbutyric acid results in increased expression of CDKN1A protein |
CTD |
PMID:17210717 PMID:23770000 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN2A mRNA |
CTD |
PMID:17210717 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] |
CTD |
PMID:34973135 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
multiple interactions increases activity |
ISO |
4-phenylbutyric acid results in increased activity of and affects the localization of CFTR protein mutant form; 4-phenylbutyric acid results in increased stability of and affects the localization of CFTR protein 4-phenylbutyric acid results in increased activity of CFTR protein mutant form |
CTD |
PMID:14583596 PMID:15191910 PMID:15880796 |
|
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of CIDEC mRNA] |
CTD |
PMID:28962527 |
|
NCBI chr 6:113,401,595...113,412,721
Ensembl chr 6:113,401,595...113,412,721
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CITED2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:17,598,452...17,601,422
Ensembl chr10:17,598,966...17,601,422
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CLDN1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
|
|
G |
Cldn11 |
claudin 11 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of CLDN11 protein] |
CTD |
PMID:35533795 |
|
NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473
|
|
G |
Cmss1 |
cms small ribosomal subunit 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CMSS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr16:57,122,362...57,427,230
Ensembl chr16:57,122,363...57,427,227
|
|
G |
Cnih4 |
cornichon family AMPA receptor auxiliary protein 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CNIH4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:180,977,437...180,996,559
Ensembl chr 1:180,972,258...180,996,559
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CNOT2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:116,321,065...116,418,891
Ensembl chr10:116,321,066...116,417,416
|
|
G |
Col10a1 |
collagen, type X, alpha 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased expression of COL10A1 protein] |
CTD |
PMID:29653943 |
|
NCBI chr10:34,265,977...34,273,081
Ensembl chr10:34,265,977...34,273,081
|
|
G |
Col5a1 |
collagen, type V, alpha 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of COL5A1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4I1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of COX4I1 protein] |
CTD |
PMID:36473502 |
|
NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
|
|
G |
Csde1 |
cold shock domain containing E1, RNA binding |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CSDE1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:102,927,347...102,965,502
Ensembl chr 3:102,927,742...102,965,502
|
|
G |
Csf1 |
colony stimulating factor 1 (macrophage) |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CSF2 protein] |
CTD |
PMID:35413383 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF3 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of CSPG5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:110,072,851...110,091,644
Ensembl chr 9:110,072,851...110,091,644
|
|
G |
Cst3 |
cystatin C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and affects the localization of CST3 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CTSD protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CTSD protein] |
CTD |
PMID:27638906 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; [4-phenylbutyric acid co-treated with N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide] results in decreased expression of CXCL8 protein 4-phenylbutyric acid results in decreased expression of CXCL8 protein |
CTD |
PMID:17709599 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of CYCS protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CYCS protein] |
CTD |
PMID:29306025 PMID:37741534 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions decreases expression decreases phosphorylation |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Cyclosporine results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Leflunomide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [nefazodone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [perhexiline maleate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]] 4-phenylbutyric acid results in decreased expression of DDIT3 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [anandamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA] 4-phenylbutyric acid results in decreased phosphorylation of DDIT3 protein |
CTD |
PMID:24053669 PMID:24865413 PMID:25295624 PMID:25450231 PMID:26513129 PMID:26804720 PMID:27470132 PMID:27484784 PMID:27578021 PMID:27613715 PMID:27634458 PMID:27638049 PMID:27816613 PMID:28063906 PMID:28245985 PMID:28698385 PMID:28844859 PMID:28988120 PMID:29653943 PMID:29981725 PMID:30025493 PMID:30602124 PMID:30980806 PMID:31298478 PMID:31364909 PMID:31891755 PMID:32407927 PMID:32578922 PMID:32590070 PMID:32879258 PMID:33309543 PMID:33651226 PMID:33677747 PMID:33771661 PMID:33922211 PMID:34214594 PMID:34958886 PMID:35033536 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36030031 PMID:36646296 PMID:37741534 More...
|
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddx55 |
DEAD box helicase 55 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of DDX55 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:124,690,895...124,707,723
Ensembl chr 5:124,690,927...124,707,723
|
|
G |
Derl1 |
Der1-like domain family, member 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of DERL1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr15:57,732,898...57,755,814
Ensembl chr15:57,732,898...57,755,844
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of DGAT1 mRNA] |
CTD |
PMID:36670177 |
|
NCBI chr15:76,386,215...76,396,167
Ensembl chr15:76,386,215...76,396,153
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions decreases expression |
EXP |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DNAJB9 mRNA] 4-phenylbutyric acid results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:28698385 PMID:28962527 |
|
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions increases phosphorylation |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of DNM1L protein] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and affects the localization of DNM1L protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DNM1L protein] 4-phenylbutyric acid results in increased phosphorylation of DNM1L protein |
CTD |
PMID:33651226 |
|
NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
|
|
G |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
multiple interactions decreases expression |
EXP |
4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of EDEM1 mRNA] 4-phenylbutyric acid results in decreased expression of EDEM1 mRNA |
CTD |
PMID:23274897 PMID:28698385 |
|
NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
|
|
G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of EEF1E1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:38,829,667...38,843,004
Ensembl chr13:38,828,183...38,843,034
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:102,729,298...102,771,999
Ensembl chr11:102,729,299...102,771,811
|
|
G |
Egfl7 |
EGF-like domain 7 |
increases expression multiple interactions |
ISO |
4-phenylbutyric acid results in increased expression of EGFL7 mRNA alternative form [decitabine co-treated with 4-phenylbutyric acid] results in increased expression of EGFL7 mRNA alternative form |
CTD |
PMID:19116145 |
|
NCBI chr 2:26,471,095...26,482,694
Ensembl chr 2:26,470,026...26,483,132
|
|
G |
Ehd3 |
EH-domain containing 3 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of EHD3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:74,111,836...74,139,088
Ensembl chr17:74,111,129...74,139,089
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of EIF2A protein] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of EIF2A mRNA] |
CTD |
PMID:31364909 PMID:34175825 |
|
NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression multiple interactions |
ISO EXP |
4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2AK3 protein modified form] 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of EIF2AK3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased phosphorylation of EIF2AK3 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form] 4-phenylbutyric acid results in decreased expression of EIF2AK3 protein; 4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:27470132 PMID:27484784 PMID:27638906 PMID:28063906 PMID:28245985 PMID:29653943 PMID:30796460 PMID:31364909 PMID:32569804 PMID:33651226 PMID:34175825 PMID:35533795 PMID:36005737 PMID:36646296 PMID:37692514 PMID:37741534 More...
|
|
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Atorvastatin results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid results in decreased expression of and results in increased phosphorylation of EIF2S1 protein 4-phenylbutyric acid results in decreased expression of EIF2S1 protein modified form 4-phenylbutyric acid affects the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of EIF2S1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2S1 protein modified form] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of EIF2S1 mRNA]; 4-phenylbutyric acid inhibits the reaction [anandamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of EIF2S1 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:20876807 PMID:25295624 PMID:26513129 PMID:26804720 PMID:27484784 PMID:27638049 PMID:27638906 PMID:28063906 PMID:28844859 PMID:29653943 PMID:30602124 PMID:33651226 PMID:34214594 PMID:34520753 PMID:35413383 PMID:35533795 PMID:36670177 More...
|
|
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of ERN1 protein modified form] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Asbestos, Amosite results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of ERN1 protein] 4-phenylbutyric acid results in decreased expression of ERN1 protein 4-phenylbutyric acid results in increased expression of ERN1 protein 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ERN1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of ERN1 mRNA] |
CTD |
PMID:20399799 PMID:23885834 PMID:29444456 PMID:30796460 PMID:33651226 PMID:34520753 PMID:35413383 PMID:36030031 PMID:36646296 PMID:37692514 More...
|
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of FAAH mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:115,853,866...115,876,034
Ensembl chr 4:115,824,342...115,875,123
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase, beta subunit |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of FARSB mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:78,394,593...78,465,530
Ensembl chr 1:78,394,612...78,465,534
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA] 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of FASN mRNA] |
CTD |
PMID:32407927 PMID:36670177 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of FBLN1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] |
CTD |
PMID:30980806 |
|
NCBI chr15:58,039,275...58,078,288
Ensembl chr15:58,039,275...58,078,328
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of FGF2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
|
|
G |
Fis1 |
fission, mitochondrial 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of FIS1 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
|
|
G |
Fkbp11 |
FK506 binding protein 11 |
multiple interactions |
EXP |
4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr15:98,622,249...98,626,079
Ensembl chr15:98,622,247...98,626,079
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:25398788 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 protein] |
CTD |
PMID:36030031 |
|
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of FOXO3 protein] 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased phosphorylation of FOXO3 protein] |
CTD |
PMID:33127495 PMID:34214594 |
|
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of GAS5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:160,862,171...160,866,109
Ensembl chr 1:160,861,992...160,866,116
|
|
G |
Gas6 |
growth arrest specific 6 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of GAS6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:13,515,374...13,544,535
Ensembl chr 8:13,515,374...13,544,490
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of GJA1 protein] |
CTD |
PMID:35533795 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Gpd2 |
glycerol phosphate dehydrogenase 2, mitochondrial |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of GPD2 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 2:57,127,690...57,260,731
Ensembl chr 2:57,127,647...57,260,731
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of GPT protein] 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased activity of GPT protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of GPT protein] 4-phenylbutyric acid inhibits the reaction [TAK-875 results in increased expression of GPT protein]; 4-phenylbutyric acid inhibits the reaction [triptolide results in increased expression of GPT protein] |
CTD |
PMID:27470132 PMID:28063906 PMID:28844859 PMID:30243991 PMID:36520315 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of GPX3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of GPX4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of GRB10 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:11,880,499...11,987,428
Ensembl chr11:11,880,508...11,988,683
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of GSDMD mRNA] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of GSDMD protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of GSDMD protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 |
|
NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
|
|
G |
H2-T23 |
histocompatibility 2, T region locus 23 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HLA-E mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[4-phenylbutyric acid affects the acetylation of HDAC1 protein] which affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hdac3 |
histone deacetylase 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased expression of HDAC3 protein] |
CTD |
PMID:34973135 |
|
NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression multiple interactions |
ISO |
4-phenylbutyric acid results in increased expression of HGF mRNA; 4-phenylbutyric acid results in increased expression of HGF protein 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF protein] |
CTD |
PMID:28844859 |
|
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HK2 protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 6:82,702,004...82,751,437
Ensembl chr 6:82,702,006...82,751,435
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HMGA1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:27,774,798...27,782,649
Ensembl chr17:27,775,471...27,782,648
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HMGA2 protein] 4-phenylbutyric acid results in decreased expression of HMGA2 protein |
CTD |
PMID:36473502 |
|
NCBI chr10:120,197,173...120,312,374
Ensembl chr10:120,197,180...120,312,374
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
|
|
G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HNRNPC mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:52,310,834...52,341,462
Ensembl chr14:52,310,834...52,341,485
|
|
G |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HS6ST mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:36,107,481...36,145,527
Ensembl chr 1:36,107,481...36,145,527
|
|
G |
Hspa1a |
heat shock protein 1A |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA1A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hspa2 |
heat shock protein 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
|
|
G |
Hspa4l |
heat shock protein 4 like |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA4L mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:40,698,664...40,750,538
Ensembl chr 3:40,699,814...40,750,538
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions decreases expression |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[2,3,5-trichloro-6-phenyl-(1,4)benzoquinone co-treated with malondialdehyde-low density lipoprotein, human] results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tributyltin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of HSPA5 protein] 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] |
CTD |
PMID:17459145 PMID:20165829 PMID:23743301 PMID:25295624 PMID:26804720 PMID:27470132 PMID:27484784 PMID:27578021 PMID:27638049 PMID:27816613 PMID:28063906 PMID:28245985 PMID:28698385 PMID:28844859 PMID:29981725 PMID:30602124 PMID:30980806 PMID:31298478 PMID:31364909 PMID:31891755 PMID:32407927 PMID:32434321 PMID:32569804 PMID:32590070 PMID:32879258 PMID:33677747 PMID:33771661 PMID:33922211 PMID:34958886 PMID:35297523 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36005737 PMID:36030031 PMID:36640941 PMID:36646296 PMID:37148176 PMID:37741534 More...
|
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPH1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
|
|
G |
Id1 |
inhibitor of DNA binding 1, HLH protein |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of ID1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IFNB1 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNB1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNG mRNA]; 4-phenylbutyric acid results in decreased expression of and results in decreased secretion of IFNG protein |
CTD |
PMID:35413383 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL10 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL10 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL17A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL17A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of IL18 mRNA] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of and results in increased secretion of IL18 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased secretion of IL18 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1B mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased cleavage of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein] |
CTD |
PMID:17709599 PMID:28245985 PMID:30796460 PMID:35297523 PMID:35413383 PMID:36646296 PMID:37692514 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL6 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; 4-phenylbutyric acid inhibits the reaction [SR 1078 results in increased expression of IL6 protein] 4-phenylbutyric acid results in decreased expression of IL6 mRNA |
CTD |
PMID:17709599 PMID:28245985 PMID:28698385 PMID:35413383 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]] 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]] |
CTD |
PMID:20165829 PMID:32283200 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Ins2 |
insulin II |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]] |
CTD |
PMID:20165829 PMID:32283200 |
|
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
|
|
G |
Ipo11 |
importin 11 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of IPO11 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:106,930,947...107,073,466
Ensembl chr13:106,930,947...107,073,466
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:31298478 |
|
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
|
|
G |
Kmt5b |
lysine methyltransferase 5B |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of KMT5B mRNA |
CTD |
PMID:14583596 |
|
NCBI chr19:3,816,436...3,868,303
Ensembl chr19:3,817,421...3,868,303
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of LDHA protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
EXP |
4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of GPD2 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of MAFA mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of NKX6-1 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PCX mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PDX1 mRNA]; 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of EDEM1 mRNA]; 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Mafa |
MAF bZIP transcription factor A |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of MAFA mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr15:75,617,350...75,620,170
Ensembl chr15:75,617,339...75,620,077
|
|
G |
Magea9 |
MAGE family member A9 |
multiple interactions |
ISO |
4-phenylbutyric acid affects the reaction [Decitabine affects the expression of MAGEA9 mRNA]; 4-phenylbutyric acid affects the reaction [Decitabine affects the expression of MAGEA9 protein] |
CTD |
PMID:17290406 |
|
NCBI chr X:63,217,154...63,222,385
Ensembl chr X:63,217,154...63,222,384
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased lipidation of MAP1LC3B protein]; Curcumin inhibits the reaction [4-phenylbutyric acid results in decreased expression of MAP1LC3B protein] |
CTD |
PMID:26804720 PMID:30025493 PMID:36058351 PMID:36640941 PMID:36700298 PMID:37148176 PMID:37741534 More...
|
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] 4-phenylbutyric acid results in decreased expression of MAP3K5 protein |
CTD |
PMID:29444456 |
|
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK1 protein] 4-phenylbutyric acid results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21147958 PMID:34520753 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK3 protein] 4-phenylbutyric acid results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21147958 PMID:34520753 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK8 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of MAPK8 mRNA] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:21147958 PMID:31364909 PMID:35413383 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:21147958 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MAT2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
multiple interactions |
ISO |
[4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
|
|
G |
Mef2a |
myocyte enhancer factor 2A |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] |
CTD |
PMID:20165829 |
|
NCBI chr 7:66,880,911...67,026,435
Ensembl chr 7:66,880,911...67,022,606
|
|
G |
Met |
met proto-oncogene |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA] |
CTD |
PMID:28844859 |
|
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression multiple interactions |
ISO |
4-phenylbutyric acid results in increased expression of MFN2 protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of MFN2 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Mief1 |
mitochondrial elongation factor 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MIEF1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr15:80,118,284...80,137,572
Ensembl chr15:80,118,219...80,137,572
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased secretion of MPO protein] |
CTD |
PMID:35413383 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Mrps18c |
mitochondrial ribosomal protein S18C |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MRPS18C mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:100,946,625...100,952,333
Ensembl chr 5:100,946,493...100,952,337
|
|
G |
Mrps22 |
mitochondrial ribosomal protein S22 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MRPS22 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:98,470,783...98,483,732
Ensembl chr 9:98,470,783...98,483,713
|
|
G |
mt-Nd1 |
NADH dehydrogenase 1, mitochondrial |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of ND1 protein] |
CTD |
PMID:36473502 |
|
NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of MTOR protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of MTOR protein] 4-phenylbutyric acid results in decreased phosphorylation of MTOR protein |
CTD |
PMID:28245985 PMID:36640941 PMID:37148176 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NCF1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NCF1 protein] |
CTD |
PMID:20399799 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of NCOA4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812
|
|
G |
Nde1 |
nudE neurodevelopment protein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NDE1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr16:13,981,139...14,010,792
Ensembl chr16:13,981,139...14,010,792
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] |
CTD |
PMID:20399799 PMID:32407927 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:28245985 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nifk |
nucleolar protein interacting with the FHA domain of MKI67 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NIFK mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:118,249,573...118,261,561
Ensembl chr 1:118,249,569...118,261,552
|
|
G |
Nkx6-1 |
NK6 homeobox 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of NKX6-1 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 5:101,807,050...101,812,577
Ensembl chr 5:101,806,005...101,812,862
|
|
G |
Nln |
neurolysin (metallopeptidase M3 family) |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NLN mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:104,159,558...104,246,170
Ensembl chr13:104,159,565...104,246,122
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of NLRP3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of NLRP3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NLRP3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 PMID:37692514 |
|
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NOLC1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr19:46,064,286...46,073,982
Ensembl chr19:46,064,302...46,073,969
|
|
G |
Nom1 |
nucleolar protein with MIF4G domain 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NOM1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:29,637,338...29,658,504
Ensembl chr 5:29,639,662...29,662,841
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of NR1D2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] |
CTD |
PMID:35533795 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Ostn |
osteocrin |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA] |
CTD |
PMID:30602124 |
|
NCBI chr16:27,125,733...27,169,959
Ensembl chr16:27,126,239...27,169,962
|
|
G |
Padi2 |
peptidyl arginine deiminase, type II |
decreases expression |
EXP |
4-phenylbutyric acid results in decreased expression of PADI2 mRNA |
CTD |
PMID:28698385 |
|
NCBI chr 4:140,633,685...140,679,897
Ensembl chr 4:140,633,655...140,679,897
|
|
G |
Park7 |
Parkinson disease (autosomal recessive, early onset) 7 |
multiple interactions increases expression |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] 4-phenylbutyric acid results in increased expression of PARK7 mRNA; 4-phenylbutyric acid results in increased expression of PARK7 protein [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide; [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Oxidopamine |
CTD |
PMID:17459145 PMID:21372141 |
|
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein] 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of PARP1 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of PARP1 protein modified form] 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased cleavage of PARP1 protein] |
CTD |
PMID:27578021 PMID:27634458 PMID:29981725 PMID:32407927 PMID:34214594 PMID:35288263 PMID:37741534 More...
|
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pawr |
PRKC, apoptosis, WT1, regulator |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PAWR mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
|
|
G |
Pcx |
pyruvate carboxylase |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PCX mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
|
|
G |
Pdcd2l |
programmed cell death 2-like |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PDCD2L mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:33,883,922...33,896,154
Ensembl chr 7:33,883,924...33,896,086
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PDX1 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 5:147,206,907...147,212,658
Ensembl chr 5:147,206,769...147,212,658
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein] |
CTD |
PMID:37692514 |
|
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
|
|
G |
Pkm |
pyruvate kinase, muscle |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of PKM protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
|
|
G |
Pole4 |
polymerase (DNA-directed), epsilon 4 (p12 subunit) |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of POLE4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:82,593,513...82,629,985
Ensembl chr 6:82,595,973...82,682,346
|
|
G |
Polr1h |
RNA polymerase I subunit H |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of POLR1H mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:37,265,250...37,269,417
Ensembl chr17:37,265,248...37,269,451
|
|
G |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
increases expression decreases expression |
ISO |
4-phenylbutyric acid results in increased expression of POLR2A mRNA 4-phenylbutyric acid results in decreased expression of POLR2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:69,624,823...69,649,459
Ensembl chr11:69,624,823...69,649,463
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] |
CTD |
PMID:36670177 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein] 4-phenylbutyric acid inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA] |
CTD |
PMID:20165829 PMID:28482072 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Ppil1 |
peptidylprolyl isomerase (cyclophilin)-like 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PPIL1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:29,469,809...29,482,945
Ensembl chr17:29,469,777...29,483,160
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of PTGS2 protein] |
CTD |
PMID:17709599 PMID:36700298 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of PYCARD mRNA] 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of PYCARD protein] |
CTD |
PMID:30796460 PMID:36646296 |
|
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
|
|
G |
Rbm8a |
RNA binding motif protein 8a |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of RBM8A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:96,537,244...96,541,107
Ensembl chr 3:96,537,249...96,541,107
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased expression of RELA protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:28245985 PMID:34973135 PMID:36646296 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rnf185 |
ring finger protein 185 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of RNF185 protein] |
CTD |
PMID:34958886 |
|
NCBI chr11:3,365,973...3,402,956
Ensembl chr11:3,365,982...3,402,363
|
|
G |
Rpl7a |
ribosomal protein L7A |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of RPL7A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:26,800,697...26,803,330
Ensembl chr 2:26,800,776...26,803,330
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SARNP mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:128,657,633...128,713,507
Ensembl chr10:128,653,202...128,713,498
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein] |
CTD |
PMID:32407927 |
|
NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
|
|
G |
Sftpc |
surfactant associated protein C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CTSD protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ADAM17 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:27638906 |
|
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2S1 protein] |
CTD |
PMID:29653943 |
|
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Slc22a18 |
solute carrier family 22 (organic cation transporter), member 18 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of SLC22A18 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:143,027,502...143,053,071
Ensembl chr 7:143,027,473...143,053,071
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
|
|
G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein] |
CTD |
PMID:20165829 |
|
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] |
CTD |
PMID:22215663 |
|
NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
|
|
G |
Slc44a2 |
solute carrier family 44, member 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of CTL2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:21,232,015...21,266,324
Ensembl chr 9:21,231,994...21,266,324
|
|
G |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in increased expression of SLC5A6 protein] |
CTD |
PMID:36005737 |
|
NCBI chr 5:31,193,380...31,206,268
Ensembl chr 5:31,193,380...31,206,268
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of SLC7A11 protein] |
CTD |
PMID:36700298 |
|
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
|
|
G |
Slu7 |
SLU7 splicing factor homolog (S. cerevisiae) |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SLU7 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:43,324,550...43,338,809
Ensembl chr11:43,324,571...43,338,808
|
|
G |
Snca |
synuclein, alpha |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of SNCA protein]; 4-phenylbutyric acid inhibits the reaction [SNCA protein binds to SNCA protein] |
CTD |
PMID:17459145 PMID:21372141 |
|
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
|
|
G |
Snx5 |
sorting nexin 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SNX5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:144,092,043...144,112,713
Ensembl chr 2:144,092,043...144,112,826
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of SOD1 mRNA]; [4-phenylbutyric acid co-treated with Thapsigargin] results in increased expression of SOD1 mRNA |
CTD |
PMID:32578922 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [cobaltous chloride results in decreased expression of SOD3 mRNA] 4-phenylbutyric acid results in increased expression of SOD3 mRNA |
CTD |
PMID:21804221 |
|
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Sox4 |
SRY (sex determining region Y)-box 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SOX4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in decreased expression of SQSTM1 protein] 4-phenylbutyric acid results in increased expression of SQSTM1 protein |
CTD |
PMID:32569804 PMID:33127495 PMID:36640941 PMID:36700298 PMID:37741534 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA] 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25398788 PMID:36670177 |
|
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
G |
Srsf10 |
serine and arginine-rich splicing factor 10 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SRSF10 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:135,582,454...135,597,219
Ensembl chr 4:135,583,058...135,597,219
|
|
G |
Syvn1 |
synovial apoptosis inhibitor 1, synoviolin |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of SYVN1 mRNA 4-phenylbutyric acid inhibits the reaction [Streptozocin results in decreased expression of SYVN1 protein] |
CTD |
PMID:14583596 PMID:30980806 |
|
NCBI chr19:6,096,586...6,103,748
Ensembl chr19:6,096,606...6,103,742
|
|
G |
Tax1bp1 |
Tax1 (human T cell leukemia virus type I) binding protein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TAX1BP1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:52,690,677...52,743,765
Ensembl chr 6:52,690,714...52,743,765
|
|
G |
Tax1bp3 |
Tax1 (human T cell leukemia virus type I) binding protein 3 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TAX1BP3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:73,067,909...73,072,872
Ensembl chr11:73,067,909...73,073,988
|
|
G |
Tg |
thyroglobulin |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in decreased expression of TG protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TG protein] |
CTD |
PMID:25295624 PMID:36005737 |
|
NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
4-phenylbutyric acid results in decreased expression of TGFB1 protein |
CTD |
PMID:25450231 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Th |
tyrosine hydroxylase |
increases expression |
EXP |
4-phenylbutyric acid results in increased expression of TH protein |
CTD |
PMID:21372141 |
|
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Timm50 |
translocase of inner mitochondrial membrane 50 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TIMM50 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:28,004,947...28,011,517
Ensembl chr 7:28,004,941...28,011,497
|
|
G |
Tmed5 |
transmembrane p24 trafficking protein 5 |
increases expression decreases expression |
ISO |
4-phenylbutyric acid results in increased expression of TMED5 mRNA 4-phenylbutyric acid results in decreased expression of TMED5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:108,269,422...108,280,486
Ensembl chr 5:108,254,232...108,280,486
|
|
G |
Tmpo |
thymopoietin |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TMPO mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:90,983,433...91,017,614
Ensembl chr10:90,983,433...91,017,177
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
EXP |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of TNF protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of TNF mRNA]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of TNF mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; 4-phenylbutyric acid inhibits the reaction [SR 1078 results in increased expression of TNF protein] 4-phenylbutyric acid results in decreased expression of TNF mRNA |
CTD |
PMID:27578021 PMID:28245985 PMID:28698385 PMID:35413383 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tra2a |
transformer 2 alpha |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TRA2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:49,220,855...49,241,182
Ensembl chr 6:49,220,858...49,240,967
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of TP53 protein] |
CTD |
PMID:30980806 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tsc2 |
TSC complex subunit 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of TSC2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
|
|
G |
Tsr1 |
TSR1 20S rRNA accumulation |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TSR1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:74,788,906...74,800,166
Ensembl chr11:74,788,897...74,800,168
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions affects expression |
ISO |
[4-phenylbutyric acid affects the acetylation of HDAC1 protein] which affects the expression of TUBB3 protein; [4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein; [decitabine co-treated with 4-phenylbutyric acid] affects the expression of TUBB3 protein 4-phenylbutyric acid affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UBA1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr X:20,524,660...20,549,420
Ensembl chr X:20,524,565...20,549,418
|
|
G |
Uba6 |
ubiquitin-like modifier activating enzyme 6 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UBA6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:86,258,579...86,320,602
Ensembl chr 5:86,257,146...86,320,662
|
|
G |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of UBE2D1 protein] |
CTD |
PMID:34958886 |
|
NCBI chr10:71,090,810...71,121,048
Ensembl chr10:71,090,810...71,121,092
|
|
G |
Ube2w |
ubiquitin-conjugating enzyme E2W (putative) |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UBE2W mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:16,611,012...16,689,676
Ensembl chr 1:16,611,014...16,689,713
|
|
G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr 5:66,833,464...66,844,577
Ensembl chr 5:66,833,434...66,844,577
|
|
G |
Uchl5 |
ubiquitin carboxyl-terminal esterase L5 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein] |
CTD |
PMID:30980806 |
|
NCBI chr 1:143,652,993...143,683,204
Ensembl chr 1:143,653,010...143,683,204
|
|
G |
Umod |
uromodulin |
increases expression |
EXP |
4-phenylbutyric acid results in increased expression of UMOD protein; 4-phenylbutyric acid results in increased expression of UMOD protein mutant form |
CTD |
PMID:24567330 |
|
NCBI chr 7:119,061,931...119,078,485
Ensembl chr 7:119,061,934...119,078,505
|
|
G |
Utp4 |
UTP4 small subunit processome component |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UTP4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:107,620,272...107,649,726
Ensembl chr 8:107,620,268...107,649,720
|
|
G |
Vcp |
valosin containing protein |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of VCP protein] |
CTD |
PMID:30980806 |
|
NCBI chr 4:42,979,964...43,000,507
Ensembl chr 4:42,979,963...43,000,507
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of VEGFA protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA protein] 4-phenylbutyric acid results in decreased expression of VEGFA protein |
CTD |
PMID:28844859 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Wdr4 |
WD repeat domain 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of WDR4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:31,713,296...31,738,946
Ensembl chr17:31,713,296...31,738,954
|
|
G |
Wwtr1 |
WW domain containing transcription regulator 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of WWTR1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:57,363,065...57,483,331
Ensembl chr 3:57,363,070...57,483,331
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [[Amiodarone results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 mRNA alternative form]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of XBP1 protein alternative form] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of XBP1 protein alternative form] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]]; 4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased splicing of XBP1 mRNA] 4-phenylbutyric acid results in decreased expression of XBP1 protein alternative form |
CTD |
PMID:20165829 PMID:23274897 PMID:25295624 PMID:27578021 PMID:27638906 PMID:28245985 PMID:29444456 PMID:30602124 PMID:30796460 PMID:31298478 PMID:33651226 PMID:33771661 PMID:34214594 PMID:35413383 PMID:36670177 PMID:37692514 More...
|
|
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
|
|
G |
Xpo5 |
exportin 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of XPO5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:46,513,737...46,554,524
Ensembl chr17:46,513,708...46,554,524
|
|
G |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of YTHDF2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:131,912,227...131,939,567
Ensembl chr 4:131,912,223...131,939,614
|
|
G |
Zbtb2 |
zinc finger and BTB domain containing 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of ZBTB2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:4,317,074...4,353,114
Ensembl chr10:4,317,075...4,338,108
|
|